LHtest

LHtest is a class of diagnostic tests designed to quantify luteinizing hormone (LH) levels in biological samples, most commonly urine or blood serum. The tests are used in clinical endocrinology and reproductive medicine to assess gonadal function, monitor puberty progression, evaluate suspected pituitary disorders, and guide fertility-related treatments. In research settings, LHtests are used to study hormonal cycles and pituitary regulation.

Technology and methods typically rely on immunoassay principles. Laboratory assays include enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays (CMIA or ECLIA), which provide quantitative LH results in international units per liter or milli-international units per milliliter. Point-of-care and at-home LHtests often use lateral flow immunochromatographic technology to deliver qualitative or semi-quantitative results, usually indicating whether LH is above a predefined threshold.

Specimens and interpretation differ by application. Urine tests are commonly used for ovulation prediction; they indicate an LH surge within a defined timeframe, often roughly 24 to 36 hours before ovulation. Serum LH testing provides precise concentration values and is used to diagnose or monitor conditions such as hypogonadotropic hypogonadism, certain pituitary disorders, or during fertility treatment planning. Reference ranges vary by age, sex, pregnancy status, assay type, and specimen.

Clinical considerations include potential interferences such as cross-reactivity with related hormones in some assays, heterophile antibodies, or calibration differences between platforms. Timing of sample collection, menstrual cycle phase, and concurrent medications can affect results, so interpretation should be made in the appropriate clinical context.